OAK RIDGE, Tennessee, August 25, 2026, 15:12 EDT
- Shares of Standard Nuclear advanced 14.7% to $13.70 in Tuesday’s session.
- The gain increased market value by approximately $283 million.
- Second-quarter earnings will be released following the close of markets on Wednesday.
- The funded backlog stood at $65 million prior to the most recent Radiant agreement.
Shares of Standard Nuclear Inc. NYSE:STDN surged 14.7% on Tuesday, with investors anticipating the nuclear-fuel firm’s first quarterly results since its listing in July. By 15:10 EDT, the stock was up $1.76 at $13.70, with 1.25 million shares changing hands.
The action increased Standard Nuclear’s market capitalization by about $283 million. This amount is over four times greater than the $65 million in funded backlog previously reported ahead of the offering.
This raises expectations. Wednesday’s report must indicate if contracted fuel work is generating revenue, instead of just adding to a distant opportunity pipeline.
Standard Nuclear is scheduled to report its second-quarter results following the close of trading on August 26. The company’s management will host a conference call at 08:30 EDT on August 27.
The company entered into a definitive agreement with Radiant Industries on August 20. The deal spans several metric tons of TRISO fuel through 2031 to supply Radiant’s one-megawatt Kaleidos microreactors. Financial details of the contract were not provided.
TRISO fuel incorporates uranium particles with special coatings, intended for use in advanced reactors. With the Radiant agreement, the order book expands beyond a previously reported $65 million in funded backlog, $157 million in customer options, and $23 million in contingent unfunded work.
The executed development deals and binding delivery obligations were only included in the funded portion. The company cautioned that optional or contingent work is not guaranteed to generate revenue.
| Analyst | Firm | Rating | Target | Date |
|---|---|---|---|---|
| Brian Lee | Goldman Sachs | Buy | $18 | Aug. 10 |
| Rinny Singh | BofA Securities | Buy | $15 | Aug. 10 |
| Christine Cho | Barclays | Overweight | $17 | Aug. 10 |
| Nicholas Amicucci | Evercore ISI | Outperform | $17 | Aug. 10 |
| Christopher Dendrinos | RBC Capital | Outperform | $11 | Aug. 10 |
The $13.70 share price is higher than RBC’s $11 target, but stays under the wider $16 average and $20 high, according to seven recommendations from August.
Short-term figures are still low. Revenue for the first quarter came in at $593,802, with cost of revenue totaling $5.0 million. Net loss stood at $7.7 million.
As of March 31, cash stood at $124.9 million. Following this, Standard Nuclear secured $150 million gross in an equity offering at $15 per share, before deductions for underwriting expenses.
The IPO reflected a cautious approach to valuation. Standard Nuclear reduced its initial offering by 50% and began trading at $13.50, lower than the set issue price. Chief Executive Kurt Terrani told Reuters the company had “more demand than we have production capability.” Reuters
On Wednesday, investors should monitor three key metrics: recognized fuel revenue, funded backlog, and production spending. Movements in these areas will indicate if the Radiant deal enhances short-term visibility or continues to be largely a projection for 2031.
Risks remain significant. Clients are responsible for sourcing enriched uranium, reactor timelines may experience delays, and reported backlog might not convert to profitable sales. The firm continues to operate at a loss and lacks a track record in industrial-scale production.
Related articles: Earnings Reports
